Sphenopalatine Ganglion Block in Endoscopic Transphenoidal Pituitary Gland Surgery

Launched by KAFRELSHEIKH UNIVERSITY · Feb 15, 2025

Keywords

ClinConnect Summary

This clinical trial is looking at two different methods of providing pain relief during a specific type of surgery known as endoscopic transsphenoidal pituitary gland surgery. The researchers want to see which method—an ultrasound-guided injection through the skin or a nasal approach—works better in reducing the amount of anesthesia needed during the surgery. They will also look at how much pain medicine is given, the stability of the patient’s vital signs during the procedure, and how well patients recover afterward.

To be eligible for this trial, participants should be in good health (classified as ASA class I or II) and scheduled for the surgery mentioned. However, people with certain allergies, skin infections, or specific health conditions, like obesity with a BMI over 35, will not be able to participate. If you join the study, you will help researchers understand the best ways to manage pain during surgery, and you will be closely monitored throughout the process to ensure your safety and comfort.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • patients belonging to American Society of Anesthesiologists (ASA) class I or II
• • patients scheduled for Endoscopic Transphenoidal Pituitary gland Surgery
• Exclusion Criteria:
• • Patients will be excluded if; .History of allergy or contraindication to any of the studied drugs.
• • Patients for whom pterygopalatine fossa block is contraindicated (patient refusal, fascial anomalies, coagulation disorder, skin infection at the injection site) .Obese patients with BMI more than 35 Kg/m2.